Terry-Ann Burrell
2019
In 2019, Terry-Ann Burrell earned a total compensation of $4.3M as Chief Financial Officer at Beam Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $200,000 |
|---|---|
| Option Awards | $3,901,485 |
| Salary | $147,180 |
| Other | $54,058 |
| Total | $4,302,723 |
Burrell received $3.9M in option awards, accounting for 91% of the total pay in 2019.
Burrell also received $200K in non-equity incentive plan, $147.2K in salary and $54.1K in other compensation.
Rankings
In 2019, Terry-Ann Burrell's compensation ranked 2,716th out of 13,971 executives tracked by ExecPay. In other words, Burrell earned more than 80.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,716 out of 13,971 | 81st |
Division Manufacturing | 979 out of 5,701 | 83rd |
Major group Chemicals And Allied Products | 323 out of 2,200 | 85th |
Industry group Drugs | 263 out of 1,886 | 86th |
Industry Biological Products, Except Diagnostic Substances | 64 out of 389 | 84th |
Source: SEC filing on April 23, 2021.
Burrell's colleagues
We found two more compensation records of executives who worked with Terry-Ann Burrell at Beam Therapeutics in 2019.